Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Cirrhosis × Aspirin × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 22 Neoplasms 13 Colonic Neoplasms 10 Breast Neoplasms 10 Venous Thromboembolism 8 Prostatic Neoplasms 8 Multiple Myeloma 7 Recurrence 6 Polycythemia Vera 6 Carcinoma, Non-Small-Cell Lung 6 Thrombocythemia, Essential 4 Neoplasms, Plasma Cell 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Thrombosis 2 Sarcoma 2 Rectal Neoplasms 2 Primary Myelofibrosis 2 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Neoplasms by Site 2 Myocardial Infarction 2 Lung Neoplasms 2 Intestinal Neoplasms 2 Intestinal Diseases 2 Inflammation 2 Gastrointestinal Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2

Interventions

Ultrasonography 3 Tomography, X-Ray Computed 2 Colonoscopy 2 tremelimumab 1 lenvatinib 1 fluoromisonidazole 1 epigallocatechin gallate 1 durvalumab 1 Weights and Measures 1 Vitamin B 6 1 Tomography 1 Tidal Volume 1 Surgical Procedures, Operative 1 Standard of Care 1 Shadowing Technique, Histology 1 Radiotherapy 1 Radiomics 1 Probiotics 1 Preoperative Exercise 1 Positron-Emission Tomography 1 Portasystemic Shunt, Transjugular Intrahepatic 1 Population Groups 1 Plasmapheresis 1 Oxaliplatin 1 Medical History Taking 1 Mebendazole 1 Liquid Biopsy 1 Introns 1 Injections 1 Hematologic Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07529262 2026-04-14

AspiRe HCC

Curtin University

Phase 3 Not yet recruiting

Carcinoma, Fibrosis, Liver Cirrhosis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡